MedTrace Logo

Efficacy of Zoledronic Acid in Osteoporosis

NCT03183557 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-09-21

No results posted yet for this study

Summary

There has been no comparative data between Zoledronic acid and Zoledronic acid combined with active vitamin D in primary and secondary osteoporosis.

Conditions

Interventions

DRUG

"Zoledronic acid", "Reclast®"

To examine the efficacy of zoledronic acid in osteoporosis

DRUG

"Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"

To examine the efficacy of zoledronic acid plus alfacalcidol in osteoporosis

Sponsors & Collaborators

  • Shinshu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2022-12-08
Completion
2025-06-08

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03183557 on ClinicalTrials.gov